Subscribe

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP - June 2021 Vol 11, No 3

Case Reports
Original Article
FDA Oncology Update
From the Literature
Symptom Management Overview
HOPA Highlights
Case Reports
Pegaspargase-Induced Diabetic Ketoacidosis in a Patient with Acute Lymphoblastic Leukemia
Ellen Madarang, PharmD, BCOP; Leslie Gallardo, PharmD, BCPS; Terrence Bradley, MD
Read More
Original Article
Denosumab for First-Line Treatment of Hypercalcemia Associated with Malignancy: Retrospective Analysis
Katherine P. Morgan, PharmD, BCOP, CPP; Yujiao Sun, PharmD; Allison Deal; Jared Weiss, MD; Amber Cipriani, PharmD, BCOP
Read More
Immune-Related Adverse Events Linked to Immune Checkpoint Inhibitors: Retrospective Analysis of a Single-Center Veteran Population
Jessica M. Tran, PharmD, BCPS; Ni-Chi Wu, PharmD, BCOP, BCPS; Rajkumar J. Sevak, PhD, RPh; Pankaj Gupta, MD, FACP
Read More
Pharmacy Resident–Led Medication Reconciliation and Patient Education Service in Adults with Leukemia Receiving Anticancer Oral Agents: A Pilot Study
Lily Y. Jia, PharmD, BCOP; Jessie Signorelli, PharmD, BCOP; Samantha O. Luk, PharmD, BCOP; E. Bridget Kim, PharmD, BCPS, BCOP; Gayle C. Blouin, PharmD, BCOP
Read More
FDA Oncology Update
Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation
Read More
Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations
Read More
Zynlonta First FDA-Approved CD19-Directed Therapy for Large B-Cell Lymphoma
Read More
Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker
Read More
Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer
Read More
Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer
Read More
Trodelvy Receives New Indication for Advanced Urothelial Cancer
Read More
Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma
Read More
From the Literature
Daily Aspirin Does Not Lower Colorectal Cancer Risk When Started After Age 70
Read More
Adjuvant Nivolumab Therapy Prolongs Disease-Free Survival in Patients with Esophageal Cancer
Read More
New Data Reveal Mismatched Need and Supply of Oncology Physicians and Pharmacists in America
Read More
Symptom Management Overview
How I Treat Anemia Associated with Lower-Risk Myelodysplastic Syndromes
Brenna Rowen, PharmD, BCOP
Read More
HOPA Highlights
The Impact of Racial Disparities in Cancer Care: Racism a Risk Factor for Poor Clinical Outcomes
Read More
Eliminating Structural Racism in Oncology Pharmacy: Individual and Organizational Responsibility
Read More
New Opportunities for Pharmacists in Clinical Trials and Drug Development After COVID-19
Read More
Immunotherapy Continues to Transform the Treatment Landscape for Advanced Non–Small-Cell Lung Cancer
Read More
Cancer Pain Management and the Opioid Conundrum: Optimizing Outcomes, Minimizing Risks
Read More
Managing Thromboembolism in Patients with Cancer: Which Are the Preferred Anticoagulants?
Read More
Copyright © Amplity Health. All rights reserved.